Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

FDA advisory committee recommends Integrilin approval

Jan. 29, 1998

Clinical development of LM-AS-013 advances at Green Cross

Jan. 29, 1998

Additional data submitted to FDA to support Novastan NDA

Jan. 26, 1998

Ortho reveals new fibrinogen receptor antagonists

Jan. 26, 1998

Lilly prepares compounds for controlling TxA2

Jan. 23, 1998

Boehringer Ingelheim develops new antiplatelet agents

Jan. 21, 1998

Lovenox/Clexane receives approvals in 11 additional countries

Jan. 20, 1998

DuPont Merck develops new factor Xa inhibitors as anticoagulants

Jan. 16, 1998

Oral heparin preparation completes additional phase I trials

Jan. 16, 1998

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...